Full Press Release Details
Viking Therapeutics to Present at H.C. Wainwright's 5th Annual NASH Investor Conference.
VKTX
Viking Therapeutics to Present at H.C. Wainwright's 5th Annual NASH Investor Conference
Key Takeaway: Viking Therapeutics to Present at H.C. Wainwright's 5th Annual NASH Investor Conference
Price reaction · baseline $6.05 (2021-10-04 close) · hit after-hours · clean, no other VKTX news in the window
day 0 close · peak
-1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss